The zebrafish homologue of Parkinson's disease ATP13A2 is essential for embryonic survival

Brain Research Bulletin

Volumn 90, Issue 1, 2013, Pages 118-126

  Lopes da Fonseca, Tomás ^a,d   Correia, Ana ^a,b   Hasselaar, Wiebren ^c   van der Linde, Herma C ^c   Willemsen, Rob ^c   Outeiro, Tiago Fleming ^a,b,d  

^a INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

^b INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

ATP13A2; Development; Kufor Rakeb syndrome; Parkinson's disease; Zebrafish

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ATP13A2 PROTEIN; MESSENGER RNA; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; EMBRYO DEVELOPMENT; LOCOMOTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PARKINSON DISEASE; POINT MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; ZEBRA FISH;

ANIMALS; COMPUTATIONAL BIOLOGY; EMBRYO, NONMAMMALIAN; EMBRYONIC DEVELOPMENT; HUMANS; LOCOMOTION; MORPHOLINOS; MUTATION; PROTON-TRANSLOCATING ATPASES; SEQUENCE HOMOLOGY; ZEBRAFISH; ZEBRAFISH PROTEINS;

EID: 84870495284     PISSN: 03619230     EISSN: 18732747     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2012.09.017     Document Type: Article

References (43)

1. Schultheis P.J., Hagen T.T., O'Toole K.K., Tachibana A., Burke C.R., McGill D.L., Okunade G.W., Shull G.E. Characterization of the P5 subfamily of P-type transport ATPases in mice. Biochemical and Biophysical Research Communications 2004, 323:731-738.
2. Najim al-Din A.S., Wriekat A., Mubaidin A., Dasouki M., Hiari M. Pallido-pyramidal degeneration, supranuclear upgaze paresis and dementia: Kufor-Rakeb syndrome. Acta Neurologica Scandinavica 1994, 89:347-352.
3. Williams D.R., Hadeed A., al-Din A.S., Wreikat A.L., Lees A.J. Kufor Rakeb disease: autosomal recessive, levodopa-responsive parkinsonism with pyramidal degeneration, supranuclear gaze palsy, and dementia. Movement Disorders 2005, 20:1264-1271.
4. Ramirez A., et al. Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase. Nature Genetics 2006, 38:1184-1191.
5. Di Fonzo A., et al. ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease. Neurology 2007, 68:1557-1562.
6. Ning Y.P., et al. PARK9-linked parkinsonism in eastern Asia: mutation detection in ATP13A2 and clinical phenotype. Neurology 2008, 70:1491-1493.
7. Djarmati A., et al. ATP13A2 variants in early-onset Parkinson's disease patients and controls. Movement Disorders 2009, 24:2104-2111.
8. Behrens M.I., et al. Clinical spectrum of Kufor-Rakeb syndrome in the Chilean kindred with ATP13A2 mutations. Movement Disorders 2010, 25:1929-1937.
9. Crosiers D., Ceulemans B., Meeus B., Nuytemans K., Pals P., Van Broeckhoven C., Cras P., Theuns J. Juvenile dystonia-parkinsonism and dementia caused by a novel ATP13A2 frameshift mutation. Parkinsonism & Related Disorders 2011, 17:135-138.
10. Santoro L., et al. Novel ATP13A2 (PARK9) homozygous mutation in a family with marked phenotype variability. Neurogenetics 2011, 12:33-39.
11. Spillantini M.G., Schmidt M.L., Lee V.M., Trojanowski J.Q., Jakes R., Goedert M. Alpha-synuclein in Lewy bodies. Nature 1997, 388:839-840.
12. Mezey E., Dehejia A.M., Harta G., Tresser N., Suchy S.F., Nussbaum R.L., Brownstein M.J., Polymeropoulos M.H. Alpha synuclein is present in Lewy bodies in sporadic Parkinson's disease. Molecular Psychiatry 1998, 3:493-499.
13. Gitler A., Chesi A., Geddie M., Strathearn K. α-Synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicity. Nature Genetics 2009.
14. Gusdon A.M., Zhu J., Van Houten B., Chu C.T. ATP13A2 regulates mitochondrial bioenergetics through macroautophagy. Neurobiology of Disease 2012, 45:962-972.
15. Grunewald A., Arns B., Seibler P., Rakovic A., Munchau A., Ramirez A., Sue C.M., Klein C. ATP13A2 mutations impair mitochondrial function in fibroblasts from patients with Kufor-Rakeb syndrome. Neurobiology of Aging 2012.
16. Xu Q., Guo H., Zhang X., Tang B., Cai F., Zhou W., Song W. Hypoxia regulation of ATP13A2 (PARK9) gene transcription. Journal of Neurochemistry 2012.
17. Recchia A., Debetto P., Negro A., Guidolin D., Skaper S.D., Giusti P. Alpha-synuclein and Parkinson's disease. The FASEB Journal 2004, 18:617-626.
18. Melrose H.L., Lincoln S.J., Tyndall G.M., Farrer M.J. Parkinson's disease: a rethink of rodent models. Experimental Brain Research 2006, 173:196-204.
19. Flinn L., Bretaud S., Lo C., Ingham P.W., Bandmann O. Zebrafish as a new animal model for movement disorders. Journal of Neurochemistry 2008, 106:1991-1997.
20. Lieschke G.J., Currie P.D. Animal models of human disease: zebrafish swim into view. Nature Reviews Genetics 2007, 8:353-367.
21. Holzschuh J., Ryu S., Aberger F., Driever W. Dopamine transporter expression distinguishes dopaminergic neurons from other catecholaminergic neurons in the developing zebrafish embryo. Mechanisms of Development 2001, 101:237-243.
22. Anichtchik O.V., Kaslin J., Peitsaro N., Scheinin M., Panula P. Neurochemical and behavioural changes in zebrafish Danio rerio after systemic administration of 6-hydroxydopamine and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Journal of Neurochemistry 2004, 88:443-453.
23. Panula P., Sallinen V., Sundvik M., Kolehmainen J., Torkko V., Tiittula A., Moshnyakov M., Podlasz P. Modulatory neurotransmitter systems and behavior: towards zebrafish models of neurodegenerative diseases. Zebrafish 2006, 3:235-247.
24. Bai Q., Mullett S.J., Garver J.A., Hinkle D.A., Burton E.A. Zebrafish DJ-1 is evolutionarily conserved and expressed in dopaminergic neurons. Brain Research 2006, 1113:33-44.
25. Flinn L., Mortiboys H., Volkmann K., Köster R.W., Ingham P.W., Bandmann O. Complex I deficiency and dopaminergic neuronal cell loss in parkin-deficient zebrafish (Danio rerio). Brain 2009, 132:1613-1623.
26. Anichtchik O., Diekmann H., Fleming A., Roach A., Goldsmith P., Rubinsztein D.C. Loss of PINK1 function affects development and results in neurodegeneration in zebrafish. Journal of Neuroscience 2008, 28:8199-8207.
27. Son O-L., Kim H-T., Ji M-H., Yoo K-W., Rhee M., Kim C-H. Cloning and expression analysis of a Parkinson's disease gene, uch-L1, and its promoter in zebrafish. Biochemical and Biophysical Research Communications 2003, 312:601-607.
28. Sheng D., et al. Deletion of the WD40 domain of LRRK2 in Zebrafish causes Parkinsonism-like loss of neurons and locomotive defect. PLoS Genetics 2010, 6:e1000914.
29. Sun Z., Gitler A.D. Discovery and characterization of three novel synuclein genes in zebrafish. Developmental Dynamics 2008, 237:2490-2495.
30. Hubbard T.J., et al. Ensembl 2009. Nucleic Acids Research 2009, 37:D690-D697.
31. Larkin M.A., et al. Clustal W and Clustal X version 2.0. Bioinformatics 2007, 23:2947-2948.
32. Hall T.A. BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symposium Series 1999, 41:95-98.
33. Gouy M., Guindon S., Gascuel O. SeaView version 4: a multiplatform graphical user interface for sequence alignment and phylogenetic tree building. Molecular Biology and Evolution 2010, 27:221-224.
34. Letunic I., Doerks T., Bork P. SMART 6: recent updates and new developments. Nucleic Acids Research 2009, 37:D229-D232.
35. Marchler-Bauer A., et al. CDD: specific functional annotation with the Conserved Domain Database. Nucleic Acids Research 2009, 37:D205-D210.
36. Thisse C., Thisse B. High-resolution in situ hybridization to whole-mount zebrafish embryos. Nature Protocols 2008, 3:59-69.
37. Tang R., Dodd A., Lai D., McNabb W.C., Love D.R. Validation of zebrafish (Danio rerio) reference genes for quantitative real-time RT-PCR normalization. Acta Biochimica et Biophysica Sinica (Shanghai) 2007, 39:384-390.
38. Axelsen K.B., Palmgren M.G. Evolution of substrate specificities in the P-Type ATPase superfamily. Journal of Molecular Evolution 1998, 84-101.
39. Madej T., Addess K.J., Fong J.H., Geer L.Y., Geer R.C., Lanczycki C.J., Liu C., Lu S., Marchler-Bauer A., Panchenko A.R., Chen J., Thiessen P.A., Wang Y., Zhang D., Bryant S.H. MMDB: 3D structures and macromolecular interactions. Nucleic Acids Research 2012, 40:D461-D464.
40. Moller A.B., Asp T., Holm P.B., Palmgren M.G. Phylogenetic analysis of P5 P-type ATPases, a eukaryotic lineage of secretory pathway pumps. Molecular Phylogenetics and Evolution 2008, 46:619-634.
41. Bretaud S., Allen C., Ingham P.W., Bandmann O. p53-dependent neuronal cell death in a DJ-1-deficient zebrafish model of Parkinson's disease. Journal of Neurochemistry 2007, 100:1626-1635.
42. Sallinen V., Kolehmainen J., Priyadarshini M., Toleikyte G., Chen Y.C., Panula P. Dopaminergic cell damage and vulnerability to MPTP in Pink1 knockdown zebrafish. Neurobiology of Disease 2010, 40:93-101.
43. Weingarten L.S., Dave H., Li H., Crawford D.A. Developmental expression of P5 ATPase mRNA in the mouse. Cellular and Molecular Biology Letters 2012, 17:153-170.